Securing Growth and Profitability
First written in FY2017. 6 of 12 entries say "Restated". Latest entry: 2026-05-14.
Qol Holdings moved to the "Worse" side of this theme in 2023, the same year as the typical company in this theme.
12 other companies' latest entry also says "Raised".
- 2026-05-14RaisedEarnings presentation
「Consolidated net sales ¥500 billion Consolidated operating income ¥35 billion」
New numerical targets were presented for consolidated net sales of ¥500 billion and consolidated operating income of ¥35 billion for the fiscal year ending March 2031, exceeding the previous medium-term targets. - FY2024SoftenedAnnual report
「To become a comprehensive healthcare company, we have set medium-term targets of consolidated revenue of ¥300 billion and operating income of ¥24 billion for further growth. We have identified improving quality, expanding scale, and achieving further growth as the key priorities and will pursue them across all businesses.」
While the medium-term revenue target of ¥300 billion was maintained, the operating income target was lowered from ¥25 billion to ¥24 billion. The key priorities were also changed from expansion of scale, profit maximization, and digitalization to improving quality, expansion of scale, and further growth. - FY2024-Q3RestatedAnnual report
「To achieve our medium-term targets in the post-COVID-19 era, we have identified expansion of scale, profit maximization, and digitalization as the three key priorities and are pursuing them across all businesses.」
We continue to pursue a policy of advancing expansion of scale, profit maximization, and digitalization across all businesses as the means of achieving our medium-term targets. - FY2024-Q1ReframedAnnual report
「To achieve our medium-term targets in the post-COVID-19 era, we have identified expansion of scale, profit maximization, and digitalization as the three key priorities and are pursuing them across all businesses.」
The means of achieving the medium-term targets were reaffirmed as expanding scale, maximizing profit, and digitalization in the post-COVID-19 business environment. - FY2023-Q2RestatedAnnual report
「To achieve its medium-term targets in the era of living with COVID-19, the group is working across all businesses as one to pursue the expansion of scale, profit maximization, and digitalization.」
We continue to pursue a policy of advancing expansion of scale, profit maximization, and digitalization across all businesses as the means of achieving our medium-term targets. - FY2022RestatedAnnual report
「To become a comprehensive healthcare company, our group has set medium-term targets of consolidated revenue of ¥300 billion and operating income of ¥25 billion for further growth. To achieve them, we have identified expanding scale, maximizing profit, and digitalization as the key priorities and will pursue them across the group.」
We continue to pursue a policy centered on medium-term targets of consolidated revenue of ¥300 billion and operating income of ¥25 billion, with expansion of scale, profit maximization, and digitalization as the means of achieving them. - FY2021RestatedAnnual report
「To become a comprehensive healthcare company, our group has set medium-term targets of consolidated revenue of ¥300 billion and operating income of ¥25 billion for further growth. To achieve them, we have identified expanding scale, maximizing profit, and digitalization as the key priorities and will pursue them across the group.」
We continue to pursue medium-term targets of consolidated revenue of ¥300 billion and operating income of ¥25 billion, with expansion of scale, profit maximization, and digitalization as the means of achieving them. - FY2020RaisedAnnual report
「To achieve further growth in this environment, our group has set medium-term targets of consolidated revenue of ¥300 billion and operating income of ¥25 billion and aims to become a comprehensive healthcare company. To this end, we will pursue three group-wide strategic priorities: governance, productivity, and branding.」
The existing growth policy was given concrete form through medium-term targets of consolidated revenue of ¥300 billion and operating income of ¥25 billion, together with three group-wide strategies. - FY2019RaisedAnnual report
「In addition to growing the two core businesses, insurance pharmacies and BPO, we will advance plans for a new business with strong synergies with our existing businesses in order to create a third core business.」
A growth policy was presented that calls for creating a third core business in addition to growing the two existing businesses. - FY2019-Q3RestatedAnnual report
「The Group aims to achieve further growth by accelerating the opening of dispensing pharmacies, creating new businesses and considering expansion into overseas markets.」
We continue to pursue a policy of further growth through accelerating the opening of insurance pharmacies, creating new businesses, and expanding our overseas business. - FY2019-Q2RestatedAnnual report
「The Group aims to achieve further growth by accelerating the opening of dispensing pharmacies, creating new businesses and considering expansion into overseas markets.」
We continue to pursue further growth by accelerating the opening of insurance pharmacies, creating new businesses, and expanding our overseas business. - FY2017First statedAnnual report
「Against this backdrop, our group aims to strengthen its management platform for sustainable growth based on the following basic strategies: ① securing growth and profitability, ② pursuing group synergies, ③ organizational streamlining, ④ creating new businesses, and ⑤ Qol Group's human resources strategy.」
Securing growth and profitability is identified as the first basic strategy for sustainable growth.